Myocardial T1 and T2 mapping sequences enable direct quantification of T1, T2, and extracellular volume fraction values, serving as robust biomarkers for diagnosis and prognosis of cardiomyopathies.
Myocardial T1 and T2 mapping techniques are increasingly integrated into routine CMR for diagnosing and monitoring cardiomyopathies.
Cardiac magnetic resonance (CMR) imaging is widely used in various medical fields related to cardiovascular diseases. Rapid technological innovations in magnetic resonance imaging in recent times have resulted in the development of new techniques for CMR imaging. T1 and T2 image mapping sequences enable the direct quantification of T1, T2, and extracellular volume fraction (ECV) values of the myocardium, leading to the progressive integration of these sequences into routine CMR settings. Currently, T1, T2, and ECV values are being recognized as not only robust biomarkers for diagnosis of cardiomyopathies, but also predictive factors for treatment monitoring and prognosis. In this study, we have reviewed various T1 and T2 mapping sequence techniques and their clinical applications.
Kim et al. (Sun,) conducted a review in Cardiomyopathies. Myocardial T1 and T2 Mapping was evaluated. Myocardial T1 and T2 mapping sequences enable direct quantification of T1, T2, and extracellular volume fraction values, serving as robust biomarkers for diagnosis and prognosis of cardiomyopathies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: